Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

Overview of attention for article published in Hepatology, February 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy: 2 policy sources

patent: 3 patents

Citations

dimensions_citation: 1148 Dimensions

Readers on

mendeley: 554 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Methods for treating NASH and for preventing NASH-induced HCC

Grant US-11357768-B2

United States of America

Prevention of liver cancer with safranal-based formulations

Grant US-10912741-B2

United States of America

Safranal-sorafenib combination therapy for liver cancer

Grant US-10568873-B1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.